Bioscience Animal Health PCL (BKK:BIS)

Market Cap	678.24M -15.6%
Revenue (ttm)	2.23B -2.4%
Net Income	33.94M -53.3%
EPS	0.11 -53.3%
Shares Out	314.00M
PE Ratio	19.98
Forward PE	n/a
Dividend	0.27 (12.50%)
Ex-Dividend Date	Aug 24, 2026

Volume	7,450
Open	2.180
Previous Close	2.160
Day's Range	2.160 - 2.180
52-Week Range	1.700 - 2.740
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About BKK:BIS

Bioscience Animal Health Public Company Limited, together with its subsidiaries, manufactures, imports, and distributes pharmaceutical supplies, devices, equipment, and products for livestock and companion animals in Thailand and internationally. The company offers antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. In addition, the company offers farm production consultant; disease prevention a...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2004
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BIS

Financial Performance

In 2025, BKK:BIS's revenue was 2.25 billion, a decrease of -3.01% compared to the previous year's 2.32 billion. Earnings were 38.47 million, a decrease of -40.85%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 3, 2026

Data Sources Report a data error